Annual Report and Accounts 2012/13 - Royal Devon & Exeter Hospital
Annual Report and Accounts 2012/13 - Royal Devon & Exeter Hospital
Annual Report and Accounts 2012/13 - Royal Devon & Exeter Hospital
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
40<br />
2. Our Trust <strong>Royal</strong> <strong>Devon</strong> <strong>and</strong> <strong>Exeter</strong> NHS Foundation Trust<br />
<strong>Annual</strong> <strong>Report</strong> <strong>and</strong> <strong>Accounts</strong> <strong>2012</strong>/<strong>13</strong><br />
Our Business<br />
<strong>2012</strong>/<strong>13</strong> has been a challenging year for the Trust,<br />
both operationally <strong>and</strong> financially.<br />
The external NHS environment has<br />
undergone significant change with<br />
the dissolution of Strategic Health<br />
Authorities <strong>and</strong> Primary Care Trusts<br />
<strong>and</strong> the creation of a National<br />
Commissioning Board <strong>and</strong> Clinical<br />
Commissioning Groups amongst<br />
other structural changes. The Board<br />
of Directors has considered the impact<br />
of these changes <strong>and</strong> the potential<br />
impact on the local health <strong>and</strong> social<br />
care sector as part of the work it<br />
has been undertaking in relation to<br />
developing the Trust's strategy. Over<br />
the next five years it is likely that the<br />
Trust will exp<strong>and</strong> the population base<br />
it currently serves on an acute basis<br />
from approximately 420,000 to circa<br />
800,000 <strong>and</strong>, in addition, will also<br />
seek to develop integrated services<br />
across the local community. The Trust<br />
will continue its focus on safety <strong>and</strong><br />
aims to be in the top three of Trusts<br />
across the NHS South region for its<br />
safety performance. Furthermore<br />
the importance of research <strong>and</strong><br />
development to support <strong>and</strong> further<br />
our objectives will be strengthened,<br />
including the completion of a new<br />
£23m research, innovation <strong>and</strong><br />
learning <strong>and</strong> development facility in<br />
conjunction with the University of<br />
<strong>Exeter</strong> during 20<strong>13</strong>/14.<br />
During <strong>2012</strong>/<strong>13</strong> the Trust treated more<br />
patients than ever before, in particular<br />
we experienced a rise in the number<br />
of frail elderly patients admitted on an<br />
emergency basis (an increase of 6% in<br />
the number of medical patients over<br />
85 years of age). Given the hospital's<br />
population demographic profile, which<br />
has a percentage of elderly residents<br />
20 years ahead of the rest of Engl<strong>and</strong>,<br />
this trend is set to continue into the<br />
future. Ensuring we are best placed to<br />
deliver services for this group of our<br />
patients will be a key focus over the<br />
next couple of years. Currently the<br />
national tariff for emergency patients<br />
is paid at 30% for the number of<br />
patients above the baseline year of<br />
2008/09, so not only will we seek<br />
to ensure that patients are treated<br />
in the most appropriate location in<br />
the community or hospital but we<br />
aim to make these services become<br />
financially sustainable (currently it costs<br />
approximately £5m more per annum<br />
to deliver this service than we receive<br />
in income.)<br />
In addition the Trust undertook a<br />
recovery plan to address a backlog in<br />
the number of patients waiting for<br />
treatment for more than 18 weeks.<br />
This backlog was created during<br />
2011/12 due to a high number of<br />
emergency patients occupying the<br />
Trust's available beds <strong>and</strong> displacing<br />
elective patients.<br />
The Trust is on track with its plans<br />
to recover its position against this<br />
target during 20<strong>13</strong>/14 <strong>and</strong> has been<br />
able to accommodate the additional<br />
activity <strong>and</strong> extra emergency patients<br />
due to the construction of two new<br />
modular wards. These were opened<br />
in December <strong>2012</strong> providing 48<br />
additional beds (including a short stay<br />
rehab facility.)<br />
The Trust performed well against<br />
other operational targets including<br />
improvements to its A&E four-hour<br />
target <strong>and</strong> finished the year meeting<br />
its planned governance rating with<br />
the regulator Monitor of amber red.<br />
However pressures are emerging<br />
around cancer targets <strong>and</strong> this<br />
may have an impact on the Trust's<br />
operational performance in 20<strong>13</strong>/14.<br />
Plans are currently being developed to<br />
ensure we can maintain a good service<br />
for our cancer patients.<br />
Due to the pressures outlined above,<br />
the Trust did not meet its planned<br />
surplus during <strong>2012</strong>/<strong>13</strong>, achieving a<br />
surplus (before extraordinary items)<br />
of £1.3m against a plan of £3.5m.<br />
Whilst this surplus is lower than<br />
planned, it was sufficient, together<br />
with other financial performance,<br />
for the Trust to maintain its planned<br />
Financial Risk Rating (FRR) of 3 against<br />
Monitor's compliance framework.<br />
This benchmarks comparatively with<br />
other Foundation Trusts (FTs), as at<br />
the end of Quarter 3, 49% of FTs<br />
were rated at a FRR of 3. This is the<br />
first time in recent years that the Trust<br />
has failed to meet the financial plan<br />
by more than £500k <strong>and</strong>, due to a<br />
strong cash position, this does not<br />
present any immediate concerns for<br />
the organisation. However there is<br />
a need to ensure that the Trust can<br />
remain financially sustainable in a<br />
difficult operating environment. For the<br />
next three-five years it is anticipated<br />
that the Trust will need to generate<br />
approximately £17m (representing